Receptos, Inc. 3 SEC Filings

Filed On	Filing
27 Aug 2015	Form 3: Celgene Corp /DE/, 10% owner and 1 other Holds 26,177,855 shares of Common Stock, par value $0.001 per share
29 Jul 2014	Form 3: Szela Mary T, Director No securities owned
29 Jul 2014	Form 3: Heyman Richard A., Director No securities owned
14 Apr 2014	Form 3: Hedley Mary Lynne, Director No securities owned
26 Nov 2013	Form 3: Christian Waage, Senior VP & General Counsel No securities owned
19 Jul 2013	Form 3: Mast Erle T, Director No securities owned
08 May 2013	Form 3: Burow Kristina, Director Holds 13,333 shares of Common Stock
08 May 2013	Form 3: Nashat Amir, Director
08 May 2013	Form 3: Boehm Marcus F, Chief Technology Officer Holds 161,420 shares of Common Stock
08 May 2013	Form 3: Cole Douglas G., Director Holds 0 shares of Common Stock
08 May 2013	Form 3: Peach Robert J, Chief Scientific Officer Holds 159,631 shares of Common Stock
08 May 2013	Form 3: Arch Venture Fund Vii Lp, 10% owner and 8 others Holds 114,285 shares of Common Stock
08 May 2013	Form 3: Lilly Ventures Fund I Llc, 10% owner Holds 114,285 shares of Common Stock
08 May 2013	Form 3: Flagship Ventures Fund 2007, L.p., 10% owner and 3 others Holds 114,285 shares of Common Stock
08 May 2013	Form 3: Mineo Chrysa, VP, Corporate Development Holds 125,990 shares of Common Stock
08 May 2013	Form 3: Torres S. Edward, Director Holds 114,285 shares of Common Stock
08 May 2013	Form 3: Hinkle David A, Sr. Dir. Fin, Cntrlr & CAO
08 May 2013	Form 3: Hasnain Faheem, Director Holds 536,791 shares of Common Stock
08 May 2013	Form 3: Gujrathi Sheila, Chief Medical Officer Holds 167,328 shares of Common Stock
08 May 2013	Form 3: Schmidt James R, VP Finance & Administration Holds 76,765 shares of Common Stock

Comments